A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 7268 (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Adverse reactions
- 09 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2009 Planned end date changed from 1 Aug 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
- 11 Sep 2009 Status changed from completed to recruiting as reported by ClinicalTrials.gov.